このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Gamified Dual-Task Training for Balance and Exercise Enjoyment in Children With Spastic Cerebral Palsy

2026年11月11日 更新者:Doç.Dr.Ömer Şevgin、Uskudar University

Effects of Low-Cost Gamified Motor-Cognitive Dual-Task Training on Balance and Exercise Enjoyment in Ambulatory Children and Adolescents With Spastic Cerebral Palsy Aged 11-17 Years: A Randomized Controlled Trial

This randomized controlled trial will investigate whether a low-cost gamified motor-cognitive dual-task training program improves balance and exercise enjoyment more than standard single-task balance training in ambulatory children and adolescents with spastic cerebral palsy aged 11-17 years. Sixty participants attending a special education and rehabilitation center will be randomly assigned to one of two groups. Both groups will continue their routine physiotherapy and receive 30-minute balance training sessions twice a week for 12 weeks. The control group will perform standard single-task balance exercises, while the intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (e.g., counting backwards, naming categories, selecting colored targets) delivered in a game format with low-cost equipment (balls, colored tape, cones, steps). Balance (Pediatric Balance Scale), timed up and go performance under single- and dual-task conditions, gross motor function, walking capacity and exercise enjoyment will be assessed at baseline, after 12 weeks and at a 4-week follow-up by an assessor blinded to group allocation.

調査の概要

詳細な説明

Background: Balance impairment is a core limitation in children with spastic cerebral palsy (CP). Dual-task training, which combines motor and cognitive tasks, has been shown in meta-analyses to improve balance more than single-task training; however, most programs rely on computer- or virtual-reality-based systems, and the effect of low-cost, device-free gamified dual-task programs on both balance and exercise enjoyment has not been investigated.

Design: Assessor-blinded, two-arm, parallel-group, 1:1 randomized controlled trial with a 12-week intervention and a 4-week follow-up. Participants will be stratified by Gross Motor Function Classification System (GMFCS) level (I-II vs III) and randomized using a computer-generated block randomization list with sequentially numbered, opaque, sealed envelopes prepared by an investigator not involved in treatment or assessment.

Interventions: Both groups will continue routine physiotherapy (2 sessions/week, 40 minutes) at the center and will additionally receive balance training 2 days/week, 30 minutes/session, for 12 weeks. The control group will receive standard single-task balance training (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow and compliant surfaces) with verbal instructions and without concurrent cognitive tasks. The intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (serial subtraction, category naming, letter-number sequencing, stepping or throwing to colored targets according to verbal cues, simple arithmetic) delivered in a game format (colored targets, ball games, points/stars per session, weekly level progression, personal best records). Progression will be applied every 2 weeks along motor (support surface, speed, vision) and, in the intervention group, cognitive (task difficulty) dimensions. All sessions will be delivered by the same physiotherapist according to a written protocol and documented on a session log. No digital devices will be used.

Outcomes: Assessments will be performed at baseline (T0), at the end of the 12-week intervention (T1) and 4 weeks after the end of the intervention (T2) by a second physiotherapist blinded to group allocation. The primary outcome is the Pediatric Balance Scale. Secondary outcomes are the Timed Up and Go test under single- and dual-task (serial subtraction) conditions and the derived dual-task cost, the Gross Motor Function Measure-88 dimensions D and E, the 1-Minute Walk Test and the Physical Activity Enjoyment Scale (PACES-8, Turkish version). All scales have validated Turkish versions.

Sample size: Based on the minimal clinically important difference of the Pediatric Balance Scale in children with CP (approximately 5.8 points, SD approximately 7; effect size d = 0.80), alpha = 0.05 and power = 80%, 26 participants per group are required; allowing for 15% attrition, 30 participants per group (total 60) will be recruited.

Analysis: Intention-to-treat analysis with multiple imputation for missing data. The primary outcome at 12 weeks will be compared between groups by analysis of covariance adjusted for baseline score and GMFCS stratum. Changes across the three time points will be analyzed with linear mixed-effects models including group, time and group × time interaction. Effect sizes (partial eta squared, Cohen d) with 95% confidence intervals will be reported. Significance will be set at p < 0.05.

研究の種類

介入

入学 (推定)

60

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Güngören
      • Istanbul、Güngören、トルコ(Türkiye)
        • Bizim Çocuklarımız SPECIAL EDUCATION AND REHABILITATION CENTER
        • コンタクト:
          • Amin Danesfhar

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

11年~17年 (子)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Age 11-17 years
  • Diagnosis of spastic (unilateral or bilateral) cerebral palsy confirmed by a pediatric neurologist
  • Gross Motor Function Classification System (GMFCS) level I, II or III
  • Ability to walk independently for at least 10 meters with or without an assistive device
  • Ability to understand and follow two-step verbal commands
  • Receiving physiotherapy at the study center twice a week for at least 3 months
  • Written informed consent from the parent/legal guardian and written assent from the participant

Exclusion Criteria:

  • Botulinum toxin injection to the lower extremities within the last 6 months
  • Orthopedic surgery within the last 6 months
  • Uncontrolled epilepsy
  • Uncorrected visual or hearing impairment
  • Severe intellectual disability preventing performance of the cognitive tasks (counting, color discrimination)
  • Participation in another structured balance or exercise program during the study period
  • Uncontrolled cardiac or respiratory disease precluding exercise

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Gamified motor-cognitive dual-task training

Routine physiotherapy (2 sessions/week, 40 min) plus gamified motor-cognitive dual-task balance training, 2 days/week, 30 min/session, for 12 weeks. Motor balance tasks are combined with simultaneous cognitive tasks and delivered in a game format using low-cost equipment.

Balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed simultaneously with cognitive tasks (serial subtraction by 3s progressing to 7s, category naming, letter-number sequencing, stepping/throwing to colored targets on verbal cue, simple arithmetic). Delivered in a game format: colored floor and wall targets, ball catching/throwing and target games, points/stars per session, weekly level progression and personal best records. Progression every 2 weeks on motor (support surface, speed, vision) and cognitive (task difficulty) dimensions. Equipment: balls, colored tape, cones, steps; no digital devices. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

アクティブコンパレータ:Standard single-task balance training

Routine physiotherapy (2 sessions/week, 40 min) plus standard single-task balance training, 2 days/week, 30 min/session, for 12 weeks. Same motor tasks as the experimental arm, delivered with verbal instructions and without concurrent cognitive tasks or game elements.

The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Pediatric Balance Scale (PBS) score at 12 weeks
時間枠:Week 12 (end of intervention)

The PBS is a 14-item functional balance scale for children, each item scored 0-4; total score 0-56, higher scores indicate better balance. Turkish version validated in children with cerebral palsy.

Week 12 (end of intervention)

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Pediatric Balance Scale (PBS) score
時間枠:Baseline, Week 12, Week 16 (4-week follow-up)

Same scale as the primary outcome; change from baseline.

Baseline, Week 12, Week 16 (4-week follow-up)
Timed Up and Go (TUG) test - single task
時間枠:Baseline, Week 12, Week 16

Time (seconds) to stand from a chair, walk 3 m, turn, return and sit; mean of three trials. Lower values indicate better functional mobility.

Baseline, Week 12, Week 16
Gross Motor Function Measure-88 (GMFM-88), Dimension D (standing)
時間枠:Baseline, Week 12, Week 16

13 items scored 0-3; dimension percentage score 0-100, higher scores indicate better gross motor function. Turkish version validated.

Baseline, Week 12, Week 16
1-Minute Walk Test (1MWT)
時間枠:Baseline, Week 12, Week 16

Distance (meters) walked in 1 minute at a comfortable pace; higher values indicate better walking capacity.

Baseline, Week 12, Week 16
Physical Activity Enjoyment Scale (PACES-8, Turkish version)
時間枠:Baseline, Week 12, Week 16

8 items rated on a 7-point Likert scale; total score 8-56, higher scores indicate greater enjoyment of physical activity.

Baseline, Week 12, Week 16

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディチェア:Amin Danesfhar、Üsküdar University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月15日

一次修了 (推定)

2027年2月20日

研究の完了 (推定)

2027年2月20日

試験登録日

最初に提出

2026年11月11日

QC基準を満たした最初の提出物

2026年11月11日

最初の投稿 (実際)

2026年11月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月11日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する